NP / PA
Central Medical Associates PLLC
Central Medical Associates PLLC was paid $4.90M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoCENTRAL MEDICAL ASSOCIATES PLLC
ELIZABETHTOWN, KY 42701
ELIZABETHTOWN, KY 42701
33aNPI1629461751assigned 03/13/2015
33bProvider typeMedical Physician Assistant
28Total paid$4.90M
24GClaims286,488
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medical Physician Assistant providers in Kentucky
Rank by total paid#3 of 45
Median peer was paid$258K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,639 | $693K | |
| 2019 | 37,564 | $704K | |
| 2020 | 39,206 | $669K | |
| 2021 | 42,872 | $750K | |
| 2022 | 50,562 | $782K | |
| 2023 | 51,478 | $813K | |
| 2024incomplete | 30,167 | $485K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 41,884 | 37,109 | $1.67M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 33,952 | 29,735 | $1.01M |
| 99490 | Ccm add 20min | 8.2% | 19,350 | 18,297 | $403K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.1% | 10,041 | 9,522 | $202K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.9% | 4,375 | 3,776 | $193K |
| 80061 | Lipid panel | 3.3% | 15,922 | 15,165 | $160K |
| 80053 | Comprehensive metabolic panel | 3.2% | 19,490 | 18,481 | $156K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 8,973 | 8,518 | $111K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 8,698 | 6,154 | $99K |
| 85027 | 1.8% | 18,034 | 17,080 | $89K | |
| 82607 | 1.7% | 8,013 | 7,623 | $83K | |
| 82746 | 1.1% | 5,189 | 4,929 | $56K |
89 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 7,759 | $55K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.1% | 2,168 | $52K |
| 90674 | <1% | 2,337 | $47K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,206 | $46K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,325 | $43K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,663 | $37K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,357 | $36K |
| 84436 | <1% | 6,385 | $34K | |
| 99401 | <1% | 916 | $22K | |
| 84466 | <1% | 2,257 | $19K | |
| 83735 | <1% | 4,049 | $19K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 339 | $17K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 398 | $17K |
| 99406 | <1% | 2,506 | $13K | |
| 99487 | Ccm add 20min | <1% | 396 | $13K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 110 | $13K |
| 97032 | <1% | 1,926 | $12K | |
| 82962 | <1% | 7,957 | $11K | |
| 82728 | <1% | 1,310 | $11K | |
| 82550 | <1% | 2,717 | $11K | |
| 99439 | <1% | 535 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 201 | $10K |
| 83540 | <1% | 2,053 | $10K | |
| 82043 | <1% | 1,767 | $7K | |
| 97164 | <1% | 311 | $7K | |
| 86140 | <1% | 1,845 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 91 | $6K |
| 99407 | <1% | 195 | $5K | |
| 99254 | <1% | 55 | $5K | |
| 90756 | <1% | 291 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 46 | $4K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 3,240 | $4K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 85 | $4K |
| 99443 | <1% | 81 | $4K | |
| 83090 | <1% | 313 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 145 | $3K |
| 82570 | <1% | 1,093 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 45 | $3K |
| 99223 | Prolong inpt eval add15 m | <1% | 52 | $3K |
| 84100 | <1% | 1,007 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 31 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 210 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 162 | $2K |
| 84550 | <1% | 872 | $2K | |
| 90661 | <1% | 245 | $2K | |
| 99385 | <1% | 40 | $2K | |
| 99442 | <1% | 66 | $2K | |
| 98968 | <1% | 101 | $2K | |
| 97161 | <1% | 31 | $1K | |
| 83550 | <1% | 1,167 | $1K | |
| 81002 | <1% | 445 | $946.48 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 114 | $589.72 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 25 | $521.44 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 70 | $475.93 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 119 | $388.78 |
| 84156 | <1% | 128 | $351.58 | |
| 90714 | <1% | 14 | $283.90 | |
| 90694 | <1% | 29 | $282.41 | |
| 90686 | <1% | 18 | $259.61 | |
| 99489 | Ccm add 20min | <1% | 15 | $258.32 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 822 | $218.59 |
| 90658 | <1% | 14 | $196.45 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 13 | $139.86 |
| 99497 | <1% | 74 | $138.77 | |
| 90653 | <1% | 12 | $85.99 | |
| 81025 | <1% | 14 | $66.73 | |
| 81000 | <1% | 28 | $34.58 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 18 | $25.51 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $21.92 |
| 3044F | <1% | 88 | $20.27 | |
| 1160F | <1% | 2,938 | $8.95 | |
| 1159F | <1% | 2,943 | $8.93 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 31 | $5.74 |
| 1125F | <1% | 471 | $1.61 | |
| 3078F | <1% | 446 | $1.29 | |
| 3074F | <1% | 316 | $0.86 | |
| 3048F | <1% | 214 | $0.55 | |
| 3075F | <1% | 39 | $0.14 | |
| 3049F | <1% | 35 | $0.07 | |
| 3050F | <1% | 16 | $0.03 | |
| 3079F | <1% | 12 | $0.02 | |
| G0008 | Administration of influenza virus vaccine | 0% | 332 | $0.00 |
| 97010 | 0% | 28 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 12 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 47 | $0.00 |
| 3008F | 0% | 30 | $0.00 | |
| 3061F | 0% | 29 | $0.00 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 74 | $0.00 |
| 2014F | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUADRI, SYED (MEMEBER)
| Provider | Location | Paid |
|---|---|---|
| Illinois Center for Pain Control LLC | Michigan City, IN | $2.62M |
| Axess Clinic and Diagnostics LLC | Michigan City, IN | $1.88M |
| Psych Pointe of Florida PLC | Orlando, FL | $303K |
| Quadri Psychiatry PLLC | Las Vegas, NV | $174K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.